What Ibuprofen Aurobindo treats: Main Uses and Benefits

Ibuprofen Aurobindo may be part of symptomatic management in situations involving certain distressing symptoms. The application of the medication for pain, inflammation, and fever is commonly understood in medical contexts for its role in supporting various acute and chronic conditions.

Easing Acute and Episodic Pain

The medication is commonly used to help with providing symptomatic relief for a wide range of symptoms related to physical discomfort, including headaches, muscular aches, dental pain, and the recurrent, disruptive symptoms associated with acute or episodic changes like menstrual cramps. It provides supportive relief when symptoms interfere with routine activities.

Supportive Management of Chronic Inflammation

Ibuprofen Aurobindo is considered relevant in clinical settings marked by increased discomfort and tension arising from inflammation, such as Rheumatoid Arthritis and Osteoarthritis. It is applied in addressing the cluster of joint pain, swelling, and stiffness in conditions where symptoms may intensify temporarily, and supports general well-being during symptomatic phases.

Moderating Fever and Systemic Illness Symptoms

Ibuprofen Aurobindo is generally applied for the short-term symptomatic management of symptoms related to systemic imbalance, specifically fever and generalized body aches associated with illnesses like the common cold or flu. It helps address the heightened manifestations of elevated temperature, contributing to easing the overall symptom load to support patient comfort and recovery.

---

Quick Fact: Relief for Pain and Inflammation
Symptom Domains: The medication is relevant for easing symptoms related to physical discomfort, systemic imbalance (fever), and inflammatory states affecting joints and soft tissues.
Conditions: It is commonly used across conditions presenting with acute episodes (sprains, headaches, dysmenorrhea) and those characterized by periods of heightened symptoms (RA, OA).
Benefits: It provides support that helps ease the overall symptom burden and assists with symptomatic management during symptomatic periods.

Official Eligibility and Contraindications

Ibuprofen Aurobindo is a nonsteroidal anti-inflammatory drug (NSAID) whose eligibility for use is defined by regulatory labels based on patient population and pre-existing medical conditions.

Who Must Not Use (Contraindicated):

Patient Group/Condition	Restriction Basis
History of allergic reaction to ibuprofen, aspirin, or other NSAIDs	Hypersensitivity
Active peptic ulcer or recurrent gastrointestinal (GI) bleeding	Active Disease Status
Severe heart, hepatic, or renal failure	Organ Function Impairment
Right before or after heart bypass surgery (CABG)	Cardiovascular Risk
Pregnant women in the last trimester (from 20 weeks gestation onward)	Fetal Harm

Age-Specific Rules:

• Children under 12 years of age are generally not eligible for standard adult tablet formulations.
• Older adults (65+ years) are eligible but must use the lowest effective dose for the shortest duration due to an increased risk of serious GI and cardiovascular events.

Use with Caution/Restriction:

Eligibility requires careful assessment for patients with mild-to-moderate renal or hepatic impairment, uncontrolled high blood pressure, or a history of heart failure (NYHA Class II-III). The medicine is also not recommended for women attempting to conceive, as NSAIDs may impair fertility.

Interactions with other medicines and products

Ibuprofen interacts with several categories of medicinal products, which may require dose adjustment, additional patient monitoring, or avoiding the combination entirely.

Interacting Product Categories and Implications:

Category	Documented Interaction Profile
Anticoagulants (e.g., warfarin) & Antiplatelet agents (e.g., low-dose aspirin)	Increased risk of bleeding and gastrointestinal complications due to enhanced effect. Concomitant use with aspirin is not generally recommended.
Other NSAIDs and Corticosteroids	Significantly increases the risk of serious adverse effects, including gastrointestinal bleeding. Concomitant use must be avoided.
Antihypertensives (e.g., ACE inhibitors, beta-blockers) & Diuretics	Ibuprofen may reduce the blood pressure-lowering effect of these medicines and can decrease the efficacy of diuretics, sometimes leading to reduced kidney function.
Lithium and Methotrexate	Ibuprofen can increase the plasma concentrations and toxicity of these medicines by reducing their renal clearance. Close monitoring and possible dose adjustments are required.

Specific Timing Constraint for Aspirin:

Ibuprofen can interfere with the antiplatelet effect of low-dose aspirin used for cardioprotection. To mitigate this, if immediate-release aspirin is taken, the ibuprofen dose should be administered at least two hours after the aspirin.

Ibuprofen Aurobindo acts by modulating key enzymatic pathways involved in prostanoid synthesis. This mechanistic activity influences localized and systemic signaling pathways.

---

Enzyme-Mediated Pathway Inhibition

Ibuprofen engages mechanisms that regulate cellular processes by non-selectively, reversibly inhibiting the cyclooxygenase (COX) enzymes, COX-1 and COX-2. This action modifies the early molecular steps within the arachidonic acid cascade, where these enzymes convert arachidonic acid into prostanoids.

---

Modulation of Prostanoid Levels

Influencing systems where specific mediators dominate, this inhibition reduces the concentration of various prostanoids (such as prostaglandins and thromboxanes). This activity influences physiological responses associated with increased mediator activity.

---

Hypothalamic Signaling Influence

The drug initiates the suppression of signaling sequences in the hypothalamus by limiting the synthesis of specific prostaglandins that act on the body's thermoregulatory center. This process alters signaling within targeted pathways, causing effects such as modified peripheral blood flow and heat transfer.

Official Administration Guidelines

Ibuprofen Aurobindo is for oral administration and is specified for short-term use only. The tablets must be swallowed whole with a glass of water and should not be chewed, crushed, or sucked on.

Dosing and Frequency

The dosage is structured by age and a strict maximum daily limit. The lowest effective dose should always be used for the shortest duration necessary.

Age Group	Single Dose	Frequency and Maximum Limit
Adults and Adolescents (≥12 years / ≥40 kg)	200 mg to 400 mg (1 to 2 tablets)	Up to three times a day, with an interval of at least four hours between doses. The total daily dose must not exceed 1200 mg in any 24-hour period.
Children under 12 years	Not recommended for use

Timing in Relation to Meals

It is recommended to take the medicine preferably with or after food, especially for patients with a sensitive stomach. Taking the dose immediately after eating may delay the onset of action, but does not substantially decrease the amount of medicine absorbed by the body.

Duration of Use

• Adults: If the medicine is required for more than 10 days, or if symptoms worsen, a healthcare provider should be consulted.
• Adolescents (12-18 years): If the medicine is required for more than 3 days, or if symptoms worsen, a healthcare provider should be consulted.

Research Evidence / Overview of Studies for Ibuprofen Aurobindo

Research related to Ibuprofen was conducted to explore how symptoms change over time in observed populations. This body of research includes controlled trials and systematic reviews. The active ingredient in Ibuprofen Aurobindo was evaluated in studies related to pain, inflammation, and fever.

---

Evidence Overview for Acute Pain and Symptoms

Research has been conducted to explore symptom management in conditions characterized by fluctuating or episodic manifestations, including those related to headache, dental discomfort, and menstrual cramps. These areas was evaluated in numerous short-term Randomized Controlled Trials (RCTs). In these trials, researchers primarily monitored patient-reported outcomes describing perceived discomfort, such as changes in pain intensity scores, over periods usually lasting only a few hours to a few days. Data show patterns related to the time taken to achieve measured changes in discomfort scores. While this research contributes to understanding symptom patterns in the short term, follow-up durations that were limited mean that long-term patterns are not fully established.

Evidence for Supportive Management of Inflammatory Conditions

Ibuprofen was evaluated in research exploring symptom patterns in conditions involving periods of heightened symptoms and functional limitations, specifically Rheumatoid Arthritis (RA) and Osteoarthritis (OA). The evidence is generally derived from intermediate-term studies, often lasting several weeks. Studies focused on outcomes linked to inflammatory or irritative states, such as measurements of joint swelling and stiffness, and functional ability. The research examined outcomes related to symptomatic relief and does not provide evidence regarding the substance’s effect on disease progression.

Understanding Research Gaps and Uncertainties

The research mainly addresses short-term symptom changes; long-term outcomes and patterns are not well characterized. Data for certain groups remain insufficient, including specific comorbidity-defined populations. Comparative evidence is lacking to definitively contrast Ibuprofen across all alternative treatments over long periods. It is critical to remember that research provides context but not individual predictions; study results reflect the specific conditions under which they were conducted.

Key Studies & References

1. DailyMed: Ibuprofen Labeling Information (Regulatory Monograph)
2. NICE Guideline NG235: Osteoarthritis in over 16s: diagnosis and management

Common questions about Ibuprofen Aurobindo (FAQ)

Q: How quickly do people usually feel the effects of Ibuprofen Aurobindo?

A: Official documents indicate that the time it takes to reach the maximum concentration in the bloodstream is approximately 45 minutes when the medicine is taken on an empty stomach. If taken with food, this peak time is generally delayed, typically observed between 1 to 2 hours after ingestion.

Q: How long does the effect of Ibuprofen Aurobindo typically last?

A: Official product information describes that the body rapidly eliminates the active substance. The elimination half-life, which is the time it takes for half of the substance to be removed from the bloodstream, is about 2 hours. Elimination is described as rapid and generally complete within a few hours.

Q: Do food or drink affect how Ibuprofen Aurobindo is absorbed?

A: Taking the medicine immediately after eating is described in official guidelines as potentially delaying the onset of action. However, the guidelines also specify that taking it with food does not substantially decrease the overall amount of medicine absorbed by the body.

Q: Does Ibuprofen Aurobindo cause fluid retention in some people?

A: Official warnings mention that fluid retention and oedema (swelling) have been reported in association with Non-Steroidal Anti-Inflammatory Drug (NSAID) therapy. Official documents note that caution is advised for patients with a history of heart failure or high blood pressure.

Q: Is Ibuprofen Aurobindo ever used for long-term conditions?

A: Official guidelines primarily specify the use of the medicine for short-term needs. For patients who may require longer treatment periods, especially with high doses, careful professional consideration and monitoring are advised, particularly for individuals with existing cardiovascular risk factors.

Q: What is the typical time frame for the maximum concentration of Ibuprofen Aurobindo in the blood?

A: The maximum concentration in the plasma, a measure of how much medicine is in the blood, is generally reached about 45 minutes after administration when taken without food. This is a technical pharmacokinetic measure often referred to as the time to peak plasma concentration.

Q: Can Ibuprofen Aurobindo be taken with antacids?

A: Official studies indicate that taking certain antacids does not typically affect how the active medicine is processed. A specific bioavailability study found that the absorption of ibuprofen was not affected when given along with a common antacid containing aluminum and magnesium hydroxide.

Q: Are there studies on the use of Ibuprofen Aurobindo in pregnancy?

A: Regulatory agencies have issued specific warnings regarding the use of NSAIDs like ibuprofen after 20 weeks of pregnancy due to the potential for fetal kidney issues and reduced amniotic fluid. Use is officially contraindicated during the third trimester of pregnancy, after 30 weeks.

Q: Can Ibuprofen Aurobindo be used for general aches and pains?

A: Official regulatory indications for the active ingredient include the temporary relief of minor aches and pains. This covers general discomfort due to common conditions such as headache, muscular aches, backache, and the minor pain of arthritis.

Q: Is there a difference in how Ibuprofen Aurobindo works compared to paracetamol?

A: The official classification of ibuprofen is as a Non-Steroidal Anti-Inflammatory Drug (NSAID), which works by reducing pain, fever, and inflammation. Paracetamol, in contrast, is primarily a pain reliever and fever reducer whose exact mechanism is less defined, and it is not considered to have significant anti-inflammatory properties.

Q: Can Ibuprofen Aurobindo cause drowsiness or affect driving?

A: Official product information advises that symptoms such as dizziness, somnolence (drowsiness), fatigue, or visual disturbances may occur during use. Official documents caution that these effects may impair a person's ability to drive or operate machinery.

Q: Is it common to have an allergic reaction to Ibuprofen Aurobindo?

A: Official regulatory safety data classifies hypersensitivity reactions as uncommon, meaning they are estimated to affect between 1 and 10 users out of every 1,000. Severe allergic reactions are also documented but are considered very rare.

Q: Are there different forms of Ibuprofen Aurobindo available, like tablets or capsules?

A: The active ingredient is available in multiple forms, and the specific Aurobindo product line often includes tablets, liquid-filled capsules, and oral suspensions. The availability of specific forms depends on the dosage strength and the specific market.

Q: What is the role of the 'Aurobindo' part of the drug name?

A: 'Aurobindo' is the name of the pharmaceutical company, Aurobindo Pharma, that is responsible for manufacturing this specific generic version of ibuprofen. This part of the name helps distinguish the product from other brands or manufacturers.

Q: Can people with diabetes use Ibuprofen Aurobindo?

A: Official warnings suggest that careful consideration should be applied before starting long-term treatment with this medicine for patients with diabetes mellitus. This caution is primarily due to a possible increased risk for cardiovascular events, especially when higher daily amounts are needed.

Q: Does Ibuprofen Aurobindo have known interaction with alcohol consumption?

A: Official warnings specifically state that the risk of serious stomach bleeding is increased for individuals who regularly consume three or more alcoholic drinks every day while using the medicine. This is highlighted as an important safety consideration.

Q: Is it common to experience stomach discomfort after taking Ibuprofen Aurobindo?

A: Gastrointestinal discomfort, such as dyspepsia (indigestion) and heartburn, is categorized in official regulatory documents as a common adverse reaction. This means it is estimated to affect between 1 and 10 users out of every 100.

Q: What kind of pain is Ibuprofen Aurobindo generally described as being effective for?

A: The medicine is generally described in official uses as being effective for the relief of mild to moderate pain. It is also indicated for symptoms associated with inflammation and fever.

Q: What is the typical clearance process for Ibuprofen Aurobindo from the body?

A: Official pharmacokinetic information describes that the active ingredient is extensively processed into inactive compounds by the liver. These resulting metabolites, along with any unchanged medicine, are then quickly and completely eliminated from the body primarily through the kidneys (via urine).

How to Store and Dispose of Ibuprofen Aurobindo?

The official storage and disposal rules for Ibuprofen Aurobindo are set by regulatory agencies to maintain product stability and ensure public safety.

Official Storage Requirements

Feature	Regulatory Requirement
Temperature	Store at 20 C to 25 C (68 F to 77 F) (USP Controlled Room Temperature).
Protection	Store in a tight light-resistant container. Avoid excessive heat above 40 C (104 F).
Child Safety	Keep this and all drugs out of the reach of children.

Official Disposal Instructions

Unused or expired medication must be disposed of in accordance with local requirements for pharmaceutical waste. This typically involves utilizing a designated drug take-back program. If a take-back program is unavailable, U.S. guidance recommends mixing the tablets with an undesirable substance, placing the mixture in a sealed bag, and discarding it in household trash, ensuring the product is not disposed of in wastewater.